News

Jefferies has upgraded Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), citing the company’s robust cystic fibrosis base business and the additional upside from the new LNP/ mRNA therapy (around $1 billion opportunity) and “triple pill” regimens. The company’s pipeline can potentially exceed expectations if the data is positive. The analyst views the risk/reward balance as mostly neutral for 2024. The pain program stands out as a potential blockbuster, especially with the upcoming launch for acute pai

JP Morgan analyst Harlan Sur maintained an Overweight rating on Broadcom Inc (NASDAQ:AVGO) with a price target of $210. Broadcom will report fiscal fourth-quarter 2024 earnings on Thursday. Sur noted a strong demand profile for AI products, continued cyclical recovery in its diversified semiconductor (ex-AI) end markets, and unlocked VMWare revenue synergy. As a result, the analyst expects revenue, earnings, and free cash flow to be better than JP Morgan and consensus expectations (revenues comi

Chinese device and now EV-maker Xiaomi revealed its latest offering in the ultra-competitive Chinese auto market, doubling down on the success it's already achieved with its SU7 EV sedan.

The company spent roughly $2.1 billion to add 21,550 bitcoins to its stash that has now grown to 423,650 BTC, and is worth close to $41.5 billion at current prices. MicroStrategy now controls over 2% of the 21 million bitcoin that will ever exist.

The key drivers of the market growth include technological advancements and a rising geriatric population, among others.

(Reuters) -U.S. consumers were bracing last month for higher levels of inflation in coming years even as they marked up expectations that their personal financial situations would improve markedly, the New York Federal Reserve reported on Monday. Respondents to the regional Fed bank's survey of consumer expectations in November see inflation a year from now at 3%, versus the 2.9% expected in October, while inflation in three years is seen at 2.6%, compared to 2.5% in the previous month. The New York Fed noted educational levels affected the view on future inflation, saying "the overall increase in one- and three-year-ahead inflation expectations masks a decline among those without a college degree and an increase among those with a college degree."

Bermuda is emerging as a hub for crypto and DeFi innovation, offering a sophisticated regulatory framework that has attracted companies like GRVT, the first regulated decentralized exchange, and Kraken, which launched its global derivatives venue there. This highlights how smaller, agile nations can bridge cutting-edge financial technologies with robust compliance, setting a precedent for fostering trust and legitimacy in the digital asset space.

U.S. equities were down at midday, pulled lower by falling tech stocks.

On Sunday, Cogent Biosciences, Inc. (NASDAQ:COGT) revealed updated clinical results from the Open Label Extension (OLE) portion of the SUMMIT trial of bezuclastinib in patients with non-advanced systemic mastocytosis. Non-advanced systemic mastocytosis is a rare disease that involves mast cell buildup in tissues and organs. Updated clinical data presented at the American Society of Hematology Annual Meeting & Exposition show: 56% mean improvement in Total Symptom Score (TSS) at 24 weeks. 76% of

Nvidia’s (NVDA) shares fell by almost 3% during mid-day trading on Monday after the Chinese government announced an investigation into the chipmaker. Fellow chipmakers Advanced Micro Devices (AMD) and Marvell (MRVL) also saw their shares fall by 4.4% and 5.2%, respectively.